VITAGERPAVAC® (Anti Herpes Vaccine) 0,3 ml/amp, 5 amps

(You save $15)
Current stock: 0


VITAGERPAVAC® is the world’s first vaccine that prevents and treats chronic recurrent Herpetic infection types I and II (HSV-1 and HSV-2). The tolerability and therapeutic effectiveness of the vaccine are provided by inactivated herpes simplex produced according to the unique technology using the Vero B continuous cell line. Vitagerpavac works by stimulating cells’ immune response to prevent infection. Clinical trials proved the efficiency of Vitagerpavac in preventing and treating herpetic infection of different localizations.


  • Treat and Prevent Recurrent Herpes Types I and II.
  • Provide a Long-Term Cellular Immunity.
  • Decrease the Frequency and Duration of HSV Recurrences.
  • Lack of Side Effects and Toxic Reactions.

100% Original from the Russian CJSC Vitapharma.All packs are air tight sealed and expire up to 12.2024.

Vitagerpavac is an inactivated herpes simplex virus types I and II culture vaccine obtained by reproduction in the Vero B cell culture. It increases protective cellular mechanisms in relation to HSV-I and HSV-II. Further read

14 days before before starting the vaccination course you need to undergo an immune strengthening preparation course with the following:

  1. Genferon 500 000 IU suppositories, 1 suppository 2 times a day for 10 days.
  2. Multivitamins 1 tablet 3 times a day for 14 days.
  3. You must avoid alcohol and spicy food 14 days prior to the start of vaccine course and during the course.


  1. Vaccination is carried out in a medical institution under the supervision of medical staff. The vaccine is used during remission stage, including ophthalmic herpes, not earlier than 10 days after the complete disappearance of the clinical manifestations of herpes infection. The vaccination course consists of 5 injections with an interval of 7 days, revaccination (repeated administration according to the same course of treatment) - after 6 months.
  2. If after the 1st or subsequent injections herpetic infection reoccurs, this means a case of pronounced immunosuppression. In such case, vaccination should be temporarily discontinued and anti-viral agents containing recombinant alpha-2 interferon (Genferon 500 000 IU suppositories) should be used to suppress the reoccurence of herpes, 1 suppository 2 times a day for 5-10 days. 10 days after the herpes rash or lesions disappear the Vitaherpavac course of treatment should be restarted from the beginning.

Each Vitagerpavac vial comes in the form of a powder to be mixed with 0,3ml water for injection. To do this, the water for injection is injected into the vial of the vaccine using a syringe with a needle, which is then shaken until the contents are completely dissolved.

1 vaccine dose (0,2ml) contains: inactivated HSV-I and HSV-II.
Excipients: gentamicin sulfate - not more than 40μg/ml, sucrose - 0.075g/ml, gelatin - 0.01g/ml, formaldehyde- 200μg/ml.

The vaccine is injected intradermally in the inner surface area of the forearm in a single dose.

The course of treatment is 5 injections, which are carried out with an interval of 7 days each.

Patients with complicated herpetic infection repeat the course after 6 months.

Note: The MHRA and FDA has not evaluated or endorsed this product. Please consult your physician prior to using this or any other nutritional supplements or medications.


Closed vials are stored in a dry place. Do not exceed medium and long-term storage temperature of 8 degrees Celcius. Can be stored for up 21 days outside of fridge. The prepared solution of a vaccine is not subject to storage. Keep away from direct sunlight. Keep locked and away from children.

Ask us any questions about Vitagerpavac.


Reviews (1)

2nd Apr 2018


Thanks for the great support and delivery of the product.

Additional Info

Additional Info

Related Products